Spot Trading’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$177K Buy
+9,600
New +$179K ﹤0.01% 2306
2016
Q4
Sell
-300
Closed -$7K 3339
2016
Q3
$7K Sell
300
-12,300
-98% -$307K ﹤0.01% 2927
2016
Q2
$301K Buy
+12,600
New +$289K 0.01% 1950
2014
Q3
Sell
-22,200
Closed -$460K 4867
2014
Q2
$460K Hold
22,200
﹤0.01% 2758
2014
Q1
$430K Buy
+22,200
New +$472K ﹤0.01% 2651

Other funds holding AMAG

Spot Trading's AMAG Position: Q4 2016 in Review

Spot Trading sold out of AMAG Pharmaceuticals (AMAG) in Q4 2016, closing a stake of 32,275 shares — an estimated $791K sold.

Spot Trading first reported a position in AMAG in Q2 2014 and held it in 4 quarters. The position peaked at $791K in Q3 2016. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

  • Spot Trading reported no remaining AMAG Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 32,275 AMAG Pharmaceuticals shares in Q4 2016, an estimated $791K.
  • Spot Trading first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • Spot Trading's AMAG Pharmaceuticals position peaked at $791K in Q3 2016.
  • 206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.